STERIS plc (STE)

Return on equity (ROE)

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net income	US$ in thousands	378,239	107,030	243,888	397,400	407,659
Total stockholders’ equity	US$ in thousands	6,302,160	6,077,200	6,532,360	3,880,990	3,405,360
ROE		6.00%	1.76%	3.73%	10.24%	11.97%

March 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $378,239K ÷ $6,302,160K
= 6.00%

STERIS plc's return on equity (ROE) has exhibited fluctuating trends over the past five years. The ROE for the fiscal year ending March 31, 2024, stood at 6.00%, showing an improvement compared to the previous year. However, it remains lower than the levels seen in FY2020 and FY2021.

The ROE for FY2023 was relatively low at 1.76%, indicating a significant decrease from the previous year's level. This suggests a decline in the company's ability to generate profit from its shareholders' equity.

In FY2022, the ROE was recorded at 3.73%, reflecting a moderate increase from the previous year but remaining at a relatively lower level compared to the two preceding years. This indicates a subdued profitability performance during that period.

STERIS plc achieved a ROE of 10.24% in FY2021, showing a notable decline compared to FY2020 when the ROE was at 11.97%. This suggests a decrease in the company's efficiency in generating profits from its equity during that year.

Overall, STERIS plc's ROE has displayed variability over the years, with fluctuations in profitability levels. It is essential for investors and stakeholders to monitor the company's ROE performance closely to assess its profitability and efficiency in utilizing shareholders' equity.